T80.A10 Non-ABO incompatibility with acute hemolytic transfusion reaction

Name of the Condition

• Non-ABO incompatibility with acute hemolytic transfusion reaction.

Summary

This condition describes an acute hemolytic transfusion reaction resulting from non-ABO blood group incompatibility. It occurs when the recipient’s immune system reacts to non-ABO antigens in transfused blood or blood products, leading to rapid hemolysis and associated clinical manifestations. The reaction is characterized by immune-mediated destruction of transfused red blood cells, which can cause significant morbidity if not promptly managed.

Causes

Acute hemolytic transfusion reactions due to non-ABO incompatibility are caused by preformed antibodies in the recipient that target minor blood group antigens (e.g., Rh, Kell, Duffy, Kidd) present in the donor blood. These antibodies may develop from prior sensitization through pregnancy, previous transfusions, or organ transplants. The reaction is triggered when incompatible blood is transfused, leading to complement activation and red blood cell lysis.

Risk Factors

• Prior exposure to non-ABO antigens (e.g., through pregnancy or previous transfusions)
• History of multiple transfusions
• Underlying immune-mediated conditions
• Use of blood products with non-ABO antigen mismatches
• Lack of pre-transfusion antibody screening in high-risk patients

Symptoms

• Fever, chills, or rigors
• Flank pain or back pain
• Hemoglobinuria (dark urine)
• Hypotension or tachycardia
• Jaundice or pallor
• Respiratory distress (wheezing, shortness of breath)
• Nausea, vomiting, or headache

Diagnosis

Diagnosis involves correlating clinical symptoms with transfusion history and performing laboratory tests. Key steps include stopping the transfusion, evaluating for hemolysis (e.g., elevated bilirubin, decreased haptoglobin, hemoglobinuria), and conducting direct antiglobulin testing or crossmatching to identify the causative antibody. Documentation of the reaction and its timing relative to the transfusion is critical.

Treatment Options

Immediate management focuses on discontinuing the transfusion, maintaining hemodynamic stability with fluids or vasopressors, and addressing hemolysis (e.g., diuresis, renal support if needed). Supportive care may include oxygen therapy, antipyretics, and monitoring for complications like acute kidney injury. In severe cases, additional interventions such as plasmapheresis or dialysis may be required.

Prognosis and Follow-Up

Prognosis depends on the severity of the reaction and promptness of treatment. Mild cases may resolve with supportive care, while severe reactions can lead to acute kidney injury, disseminated intravascular coagulation, or death. Follow-up includes monitoring renal function, hemoglobin levels, and antibody status to prevent future reactions. Long-term management may involve avoiding specific blood products or using crossmatched blood.

Complications

• Acute kidney injury or renal failure
• Disseminated intravascular coagulation (DIC)
• Shock or multiorgan failure
• Transfusion-related acute lung injury (TRALI)
• Death (in severe cases)

Lifestyle & Prevention

Prevention involves thorough pre-transfusion testing, including antibody screening and crossmatching, especially in patients with prior transfusions or pregnancies. Using leukoreduced blood products and adhering to transfusion protocols can reduce risk. Patients with a history of non-ABO reactions should receive antigen-negative or crossmatched blood to avoid future incidents.

When to Seek Professional Help

Seek immediate medical attention if symptoms such as fever, chills, flank pain, or hypotension occur during or after a transfusion. Prompt evaluation is critical to prevent severe complications. Healthcare providers should be notified of any suspected transfusion reaction for timely intervention.

Tips for Medical Coders

Document the acute hemolytic nature of the reaction and its association with non-ABO incompatibility. Include details such as timing of symptoms relative to the transfusion, laboratory findings (e.g., hemoglobinuria, positive antiglobulin test), and management provided. Ensure the code T80.A10 is used when the reaction is acute and specifically due to non-ABO incompatibility, with clear differentiation from ABO-related or unspecified reactions.